ATE291433T1 - Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen - Google Patents

Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen

Info

Publication number
ATE291433T1
ATE291433T1 AT00938038T AT00938038T ATE291433T1 AT E291433 T1 ATE291433 T1 AT E291433T1 AT 00938038 T AT00938038 T AT 00938038T AT 00938038 T AT00938038 T AT 00938038T AT E291433 T1 ATE291433 T1 AT E291433T1
Authority
AT
Austria
Prior art keywords
extract
feverfew
treating
inflammatory diseases
inflammatory disorders
Prior art date
Application number
AT00938038T
Other languages
English (en)
Inventor
Theresa Callaghan
Thierry Oddos
Gerard J Gendimenico
Katharine Martin
Original Assignee
Johnson & Johnson Consumer Fr
Theresa Callaghan
Thierry Oddos
Gerard J Gendimenico
Katharine Martin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE291433(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson Consumer Fr, Theresa Callaghan, Thierry Oddos, Gerard J Gendimenico, Katharine Martin filed Critical Johnson & Johnson Consumer Fr
Application granted granted Critical
Publication of ATE291433T1 publication Critical patent/ATE291433T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Cosmetics (AREA)
AT00938038T 1999-06-03 2000-06-02 Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen ATE291433T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13733299P 1999-06-03 1999-06-03
PCT/US2000/015125 WO2000074699A1 (en) 1999-06-03 2000-06-02 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders

Publications (1)

Publication Number Publication Date
ATE291433T1 true ATE291433T1 (de) 2005-04-15

Family

ID=22476913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938038T ATE291433T1 (de) 1999-06-03 2000-06-02 Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen

Country Status (14)

Country Link
US (1) US6410062B1 (de)
EP (1) EP1100516B1 (de)
JP (1) JP2004500329A (de)
KR (1) KR100755798B1 (de)
CN (1) CN1319020A (de)
AT (1) ATE291433T1 (de)
AU (1) AU778261B2 (de)
BR (1) BRPI0006634B8 (de)
CA (1) CA2339221C (de)
DE (1) DE60018881T2 (de)
ES (1) ES2239010T3 (de)
MX (1) MXPA01001327A (de)
PT (1) PT1100516E (de)
WO (1) WO2000074699A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
DE60220145T2 (de) 2001-03-16 2008-02-14 Johnson & Johnson Consumer Companies, Inc. Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
US20030077343A1 (en) 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20020185426A1 (en) * 2001-04-26 2002-12-12 Bealer Leroy J. Environmental flexible remediation system
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
MY139332A (en) * 2002-05-22 2009-09-30 Hovid Berhad Hair growth formulation
AU2003263162B2 (en) * 2002-10-24 2009-05-07 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040161436A1 (en) * 2003-02-13 2004-08-19 Hull Barbara A. Skin treatment composition and method
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050003025A1 (en) * 2003-06-30 2005-01-06 Hargens Robert D. Method of mitigating the odor of valerian extracts
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
KR101245440B1 (ko) * 2003-09-12 2013-03-19 액세스 비지니스 그룹 인터내셔날 엘엘씨 사이토킨 조절물질 및 관련된 용도
EP1543823A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingkoextrakt enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
EP1543822A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Soja enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
US20050244480A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Pre-wipes for improving anal cleansing
US20060003654A1 (en) * 2004-06-30 2006-01-05 Lostocco Michael R Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers
US20060147484A1 (en) * 2005-01-03 2006-07-06 Hestand Mark A Urushiol-induced contact dermatitis composition, method of use, and method of manufacture
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
WO2006128169A2 (en) * 2005-05-26 2006-11-30 The Ohio State University Research Foundation Inhibition of monocyte survival, differentiation, or proliferation
US20100227826A1 (en) * 2005-12-07 2010-09-09 Mercier Michel F Stable Flavonoid Solutions
CA2643255A1 (en) * 2006-02-21 2007-08-30 Integrated Botanical Technologies, Llc Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
CN101406514B (zh) * 2007-10-10 2011-03-23 徐柔云 一种治疗脚癣的外用药
JP2010013403A (ja) * 2008-07-04 2010-01-21 Kao Corp Ｎｆａｔシグナル阻害剤及びｎｆａｔシグナル阻害方法
FR2940127B1 (fr) * 2008-12-18 2013-07-12 Nolva Lab Compositions a usage cosmetique et dermatologique destinees a lutter contre le vieillissement de la peau et contenant un extrait titre de ginkgo biloba et un extrait purifie de lactoferrine
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
US8075930B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8075931B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8916209B2 (en) * 2009-10-02 2014-12-23 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
BR112012022106A2 (pt) 2010-03-01 2016-10-25 Johnson & Johnson Consumer composição para tratamento de pele tendo uma cor desejável em volume
US20110262505A1 (en) 2010-04-22 2011-10-27 Gina Athwal Seaweed-derived cosmetic compositions
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9173913B2 (en) * 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9724315B2 (en) * 2011-09-30 2017-08-08 Cmpd Licensing, Llc Compounded transdermal pain management
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US9468599B2 (en) 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
FR3015299B1 (fr) * 2013-12-20 2017-10-06 Oreal Dispositif d'iontophorese a gestion independante de courant
US10352605B2 (en) * 2017-02-14 2019-07-16 Heatcraft Refrigerator Products, LLC Cooling system with intermediate heat exchange fluid loop
KR102157755B1 (ko) * 2018-12-28 2020-09-18 경희대학교 산학협력단 운카리나 스텔루리페라 추출물을 유효성분으로 포함하는 항염증 또는 항아토피 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
US6103218A (en) 1997-04-23 2000-08-15 Brucker; Donald Therapeutic nasal spray administered composition containing feverfew
CA2302561C (en) * 1997-09-12 2006-02-14 The Procter & Gamble Company Cleansing and conditioning article for skin or hair

Also Published As

Publication number Publication date
EP1100516B1 (de) 2005-03-23
ES2239010T3 (es) 2005-09-16
CA2339221C (en) 2013-09-10
PT1100516E (pt) 2005-07-29
CA2339221A1 (en) 2000-12-14
MXPA01001327A (es) 2002-11-29
AU778261B2 (en) 2004-11-25
JP2004500329A (ja) 2004-01-08
EP1100516A1 (de) 2001-05-23
US6410062B1 (en) 2002-06-25
DE60018881T2 (de) 2006-02-16
BRPI0006634B1 (pt) 2015-06-02
BR0006634A (pt) 2001-05-02
KR100755798B1 (ko) 2007-09-07
AU5313000A (en) 2000-12-28
WO2000074699A1 (en) 2000-12-14
DE60018881D1 (de) 2005-04-28
BRPI0006634B8 (pt) 2021-05-25
CN1319020A (zh) 2001-10-24
KR20010072221A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
BR9916694A (pt) Composição de lenço facial e método de uso parasequestração de irritantes cutâneos de secreçãonasal
BR9916076A (pt) Composição adequada para aplicação tópica, uso de uma composição tópica métodos para melhorar o distúrbio do estìmulo sexual feminino, e para intensificar o estìmulo sexual feminino, e a resposta sexual feminina, artigo de manufatura
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE419858T1 (de) Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
BR0313492A (pt) Formulação de anticorpos humanos para tratar distúrbios associados ao tnf-alfa
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
BR0113776A (pt) Composição de pirrolocarbazóis selecionados fundidos e método para tratar e prevenir várias doenças usando a citada composição
EP1251126A3 (de) Fluor-substituierte benzensulfonyl-derivate zur behandlung von entzündungen
BR0214962A (pt) Composição para tratar distúrbios neurocerebrovasculares
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
DK0909556T3 (da) Rosaceae-ekstrakt som bradykininantagonist
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
BRPI0411324A (pt) composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes
FR2824474B1 (fr) Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0307211A (pt) Composições tópicas possuindo um ingrediente natural e método de utilização
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
DK1343472T3 (da) Thixotropisk næsespray
BR0204618A (pt) Métodos para tratamento de linhas finas e/ou de rugas, e para melhora a aparência estética da pele ou dos lábios, e, composição tópica
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100516

Country of ref document: EP